{"transactions":[{"id":933589,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2026-01-22T18:04:30.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":0.93,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001382225-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000138222526000001/primary_doc.xml","form_type":"4/A","original_submission_date":"2025-12-15"}},{"id":933588,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-22T18:04:30.000Z","date":"2025-12-12","kind":"sale","planned":false,"acquired":false,"shares":210,"price":0.9446,"value":198.366,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.9440 to $0.9451. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Amendment is being filed to correct the amount of securities beneficially owned. The Issuer effected a 1-for-30 reverse stock split of its outstanding common stock, which was not reflected on the prior Form 4."}],"balance_after":948,"source":{"system":"sec-edgar","filing":"0001382225-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000138222526000001/primary_doc.xml","form_type":"4/A","original_submission_date":"2025-12-15"}},{"id":969821,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2025-12-15T21:38:38.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":0.93,"exercise_date":"2025-12-11","expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001382225-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000138222525000002/primary_doc.xml","form_type":"4"}},{"id":969820,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-15T21:38:38.000Z","date":"2025-12-12","kind":"sale","planned":false,"acquired":false,"shares":210,"price":0.9446,"value":198.366,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions ranging from $0.9440 to $0.9451. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":34538,"source":{"system":"sec-edgar","filing":"0001382225-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000138222525000002/primary_doc.xml","form_type":"4"}},{"id":1339326,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-09T21:23:29.000Z","date":"2024-12-06","kind":"sale","planned":false,"acquired":false,"shares":3597,"price":0.36,"value":1294.92,"ownership":{"direct":true},"balance_after":34748,"source":{"system":"sec-edgar","filing":"0001493152-24-049278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224049278/ownership.xml","form_type":"4"}},{"id":1401791,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2024-09-21T01:15:43.000Z","date":"2024-09-19","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant."}],"balance_after":65000,"derivative":{"exercise_price":0.48,"exercise_date":"2024-09-19","expiration_date":"2034-09-19","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001493152-24-037734","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224037734/ownership.xml","form_type":"4"}},{"id":1725716,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T22:23:19.000Z","date":"2023-11-30","kind":"sale","planned":false,"acquired":false,"shares":3500,"price":3.5681,"value":12488.35,"ownership":{"direct":true},"balance_after":38345,"source":{"system":"sec-edgar","filing":"0001493152-23-043456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223043456/ownership.xml","form_type":"4"}},{"id":1811063,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-10T20:30:22.000Z","date":"2023-08-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023"}],"balance_after":41845,"source":{"system":"sec-edgar","filing":"0001493152-23-027582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223027582/ownership.xml","form_type":"4"}},{"id":2197967,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2022-08-02T20:35:34.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022."}],"balance_after":220000,"derivative":{"exercise_price":0.3562,"exercise_date":"2022-07-29","expiration_date":"2032-07-29","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001493152-22-021015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222021015/ownership.xml","form_type":"4"}},{"id":2221401,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2022-06-27T20:10:15.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Due to a clerical error, the Form 4, as originally filed, incorrectly reported the option expiration date. The Form 4, as amended by this Form 4/A, correctly reports such information. No other changes have been made to the originally filed Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."}],"balance_after":250000,"derivative":{"exercise_price":0.295,"exercise_date":"2022-06-23","expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-22-017831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222017831/ownership.xml","form_type":"4/A","original_submission_date":"2022-06-24"}},{"id":2222231,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2022-06-24T20:15:23.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with service to the Company as Executive Chairman of the Board. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022."}],"balance_after":250000,"derivative":{"exercise_price":0.295,"exercise_date":"2022-06-23","expiration_date":"2022-06-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-22-017710","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222017710/ownership.xml","form_type":"4"}},{"id":2225824,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T13:30:35.000Z","date":"2022-06-17","kind":"purchase","acquired":true,"shares":10084,"price":0.286,"value":2884.024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased at an average price of $0.2860 on June 17, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":1010000,"source":{"system":"sec-edgar","filing":"0001493152-22-017293","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222017293/ownership.xml","form_type":"4"}},{"id":2256985,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T20:05:31.000Z","date":"2022-05-24","kind":"purchase","acquired":true,"shares":78673,"price":0.2895,"value":22775.8335,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging between $0.2800 and $0.3000 on May 24, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":999916,"source":{"system":"sec-edgar","filing":"0001493152-22-015040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222015040/ownership.xml","form_type":"4"}},{"id":2256984,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T20:05:31.000Z","date":"2022-05-23","kind":"purchase","acquired":true,"shares":3500,"price":0.2869,"value":1004.15,"ownership":{"direct":true},"balance_after":921243,"source":{"system":"sec-edgar","filing":"0001493152-22-015040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222015040/ownership.xml","form_type":"4"}},{"id":2260313,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T20:15:29.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":65718,"price":0.2836,"value":18637.6248,"ownership":{"direct":true},"balance_after":917743,"source":{"system":"sec-edgar","filing":"0001493152-22-014790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222014790/ownership.xml","form_type":"4"}},{"id":2262196,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T20:15:26.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":56806,"price":0.2807,"value":15945.4442,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging between $0.2500 and $0.2700 on May 18, 2022 and between $0.2570 and $0.2998 on May 19, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":852025,"source":{"system":"sec-edgar","filing":"0001493152-22-014605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222014605/ownership.xml","form_type":"4"}},{"id":2262195,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T20:15:26.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":15303,"price":0.261,"value":3994.083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging between $0.2500 and $0.2700 on May 18, 2022 and between $0.2570 and $0.2998 on May 19, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":795219,"source":{"system":"sec-edgar","filing":"0001493152-22-014605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222014605/ownership.xml","form_type":"4"}},{"id":2311537,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T20:05:34.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":59053,"price":0.3517,"value":20768.9401,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging from $0.3510 to $0.3773 on March 30, 2022 and from $0.3407 to $0.3772 on March 31, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":779916,"source":{"system":"sec-edgar","filing":"0001493152-22-008799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222008799/ownership.xml","form_type":"4"}},{"id":2311536,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T20:05:34.000Z","date":"2022-03-30","kind":"purchase","acquired":true,"shares":124785,"price":0.3629,"value":45284.4765,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging from $0.3510 to $0.3773 on March 30, 2022 and from $0.3407 to $0.3772 on March 31, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":720863,"source":{"system":"sec-edgar","filing":"0001493152-22-008799","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315222008799/ownership.xml","form_type":"4"}},{"id":2466816,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-12-17T22:07:27.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021."}],"balance_after":75000,"derivative":{"exercise_price":0.49,"exercise_date":"2021-12-16","expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-21-031890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221031890/ownership.xml","form_type":"4"}},{"id":2650550,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-06-30T20:06:01.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":156540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the exercise of a fully vested outstanding option award to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the exercise of a fully vested outstanding option award to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":0.48,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":156540},"source":{"system":"sec-edgar","filing":"0001493152-21-015714","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221015714/ownership.xml","form_type":"4"}},{"id":2650549,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T20:06:01.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":156540,"price":0.48,"value":75139.2,"ownership":{"direct":true},"balance_after":596078,"source":{"system":"sec-edgar","filing":"0001493152-21-015714","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221015714/ownership.xml","form_type":"4"}},{"id":2846577,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2021-02-19T21:35:25.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021."}],"balance_after":160000,"derivative":{"exercise_price":1.2,"exercise_date":"2021-02-18","expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-21-004420","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221004420/ownership.xml","form_type":"4"}},{"id":2966389,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T21:05:35.000Z","date":"2020-11-24","kind":"purchase","acquired":true,"shares":100000,"price":0.37,"value":37000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents acquisition of shares of Common Stock through participation in the Company's underwritten public offering at the offering price per share of $0.37."}],"balance_after":439538,"source":{"system":"sec-edgar","filing":"0001493152-20-022545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220022545/ownership.xml","form_type":"4"}},{"id":3147501,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series 1 Common Stock Warrants (right to buy)","published_at":"2020-05-15T20:30:47.000Z","date":"2020-05-14","kind":"other","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2019-03-25","expiration_date":"2020-05-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-009137","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220009137/ownership.xml","form_type":"4"}},{"id":3284808,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2020-02-07T21:15:59.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":156540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020."}],"balance_after":156540,"derivative":{"exercise_price":0.48,"exercise_date":"2021-02-05","expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":156540},"source":{"system":"sec-edgar","filing":"0001493152-20-001781","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220001781/ownership.xml","form_type":"4"}},{"id":3284807,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2020-02-07T21:15:59.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":156540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the \"Plan\") that vests immediately."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the \"Plan\") that vests immediately."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the \"Plan\") that vests immediately."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the \"Plan\") that vests immediately."}],"balance_after":156540,"derivative":{"exercise_price":0.48,"exercise_date":"2020-02-05","expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":156540},"source":{"system":"sec-edgar","filing":"0001493152-20-001781","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220001781/ownership.xml","form_type":"4"}},{"id":3480245,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2019-06-24T21:05:28.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":156540,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director.  The option exercise price is the closing price on the date of the grant, June 20, 2019 (the \"Grant Date\"). The options vest quarterly in even amounts over the four quarters following the Grant Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director.  The option exercise price is the closing price on the date of the grant, June 20, 2019 (the \"Grant Date\"). The options vest quarterly in even amounts over the four quarters following the Grant Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director.  The option exercise price is the closing price on the date of the grant, June 20, 2019 (the \"Grant Date\"). The options vest quarterly in even amounts over the four quarters following the Grant Date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director.  The option exercise price is the closing price on the date of the grant, June 20, 2019 (the \"Grant Date\"). The options vest quarterly in even amounts over the four quarters following the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director.  The option exercise price is the closing price on the date of the grant, June 20, 2019 (the \"Grant Date\"). The options vest quarterly in even amounts over the four quarters following the Grant Date."}],"balance_after":156540,"derivative":{"exercise_price":0.48,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":156540},"source":{"system":"sec-edgar","filing":"0000899243-19-017958","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924319017958/doc4.xml","form_type":"4"}},{"id":3576694,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series 2 Common Stock Warrants (right to buy)","published_at":"2019-03-27T20:05:29.000Z","date":"2019-03-25","kind":"purchase","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units."}],"balance_after":50000,"derivative":{"exercise_price":0.9,"exercise_date":"2019-03-25","expiration_date":"2024-03-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-19-009014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924319009014/doc4.xml","form_type":"4"}},{"id":3576693,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series 1 Common Stock Warrants (right to buy)","published_at":"2019-03-27T20:05:29.000Z","date":"2019-03-25","kind":"purchase","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units."}],"balance_after":50000,"derivative":{"exercise_price":0.75,"exercise_date":"2019-03-25","expiration_date":"2020-09-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-19-009014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924319009014/doc4.xml","form_type":"4"}},{"id":3576692,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-27T20:05:29.000Z","date":"2019-03-25","kind":"purchase","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units."}],"balance_after":339538,"source":{"system":"sec-edgar","filing":"0000899243-19-009014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924319009014/doc4.xml","form_type":"4"}},{"id":3804444,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2018-10-01T20:05:30.000Z","date":"2018-09-27","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended in connection with service to the Company as a director.  The options vest immediately. The option exercise price is the closing price on the date of the grant, September 27, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended in connection with service to the Company as a director.  The options vest immediately. The option exercise price is the closing price on the date of the grant, September 27, 2018."}],"balance_after":125000,"derivative":{"exercise_price":0.73,"exercise_date":"2018-09-27","expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-18-025656","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924318025656/doc4.xml","form_type":"4"}},{"id":3811064,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-20T16:23:02.000Z","date":"2018-09-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be fully vested and exercisable effective on the later of the Resignation Date or the effective date of the release as long as Dr. Telling remains in good standing on the Board with the Company through the Resignation Date."}],"balance_after":60000,"derivative":{"exercise_price":1.88,"expiration_date":"2028-09-18","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000891293-18-000085","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089129318000085/primary_doc.xml","form_type":"4"}},{"id":3866464,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrants (right to buy)","published_at":"2018-07-17T20:44:26.000Z","date":"2018-07-17","kind":"purchase","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchase of Class A Units consisting of one share of common stock and one warrant to purchase one share of common stock in an underwritten public offering at the price of $1.00 per Unit, which was the price paid by the public for such Units."}],"balance_after":100000,"derivative":{"exercise_price":1,"exercise_date":"2018-07-17","expiration_date":"2025-07-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-18-019954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924318019954/doc4.xml","form_type":"4"}},{"id":3866463,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-17T20:44:26.000Z","date":"2018-07-17","kind":"purchase","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchase of Class A Units consisting of one share of common stock and one warrant to purchase one share of common stock in an underwritten public offering at the price of $1.00 per Unit, which was the price paid by the public for such Units."}],"balance_after":239538,"source":{"system":"sec-edgar","filing":"0000899243-18-019954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924318019954/doc4.xml","form_type":"4"}},{"id":3883247,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2018-06-26T20:17:18.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director.  The options vest one year from the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director.  The options vest one year from the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2018."}],"balance_after":14000,"derivative":{"exercise_price":1.52,"exercise_date":"2019-06-22","expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0000899243-18-018136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924318018136/doc4.xml","form_type":"4"}},{"id":3883246,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-26T20:17:18.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock in connection with service to the Company as a director pursuant to the 2012 Equity Incentive Plan that vests immediately."}],"balance_after":139538,"source":{"system":"sec-edgar","filing":"0000899243-18-018136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924318018136/doc4.xml","form_type":"4"}},{"id":3929284,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-05-17T18:20:40.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was granted on May 17, 2018 and vests on the first to occur of (i) the date that is twelve months after the date of grant, and (ii) immediately prior to the first annual meeting of the Company's stockholders in 2019 at which one or more members of the Company's Board of Directors are to be elected, subject to the Reporting Person's continued service through such date or event."}],"balance_after":60000,"derivative":{"exercise_price":4.61,"expiration_date":"2028-05-17","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000891293-18-000061","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089129318000061/primary_doc.xml","form_type":"4"}},{"id":4272629,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Director Option (Right to Buy)","published_at":"2017-06-26T19:27:51.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director.  The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2017"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director.  The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2017"}],"balance_after":140000,"derivative":{"exercise_price":0.37,"exercise_date":"2017-06-22","expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0000899243-17-017198","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924317017198/doc4.xml","form_type":"4"}},{"id":4338903,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-05-02T17:46:55.000Z","date":"2017-04-29","kind":"exercise","acquired":false,"shares":34736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of CTIC common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"CTIC completed a 1-for-10 reverse stock split in January 2017. All share amounts reported in this Form 4 have been retroactively adjusted to reflect this stock split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit was granted on April 29, 2016 and vested on April 29, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit was granted on April 29, 2016 and vested on April 29, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"CTIC completed a 1-for-10 reverse stock split in January 2017. All share amounts reported in this Form 4 have been retroactively adjusted to reflect this stock split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":34736},"source":{"system":"sec-edgar","filing":"0000899243-17-011488","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089924317011488/doc4.xml","form_type":"4"}},{"id":4338902,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-02T17:46:55.000Z","date":"2017-04-29","kind":"exercise","acquired":true,"shares":34736,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"CTIC completed a 1-for-10 reverse stock split in January 2017. All share amounts reported in this Form 4 have been retroactively adjusted to reflect this stock split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of CTIC common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":78874,"source":{"system":"sec-edgar","filing":"0000899243-17-011488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089924317011488/doc4.xml","form_type":"4"}},{"id":4422881,"issuer":{"id":111865,"kind":"organization","name":"CTI BIOPHARMA CORP","symbol":"CTIC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-27T17:33:06.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was granted on February 23, 2017 and vests on the first to occur of (i) the date that is twelve months after the date of grant, (ii) the first annual meeting of CTIC's shareholders in 2018 at which one or more members of the CTIC Board of Directors are to be elected, or (iii) immediately prior to the occurrence of a Change of Control (as such term is defined in CTIC's 2015 Equity Incentive Plan), subject to the Reporting Persons' continued service through such date or event."}],"balance_after":50000,"derivative":{"exercise_price":4.25,"expiration_date":"2027-02-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-17-005430","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/891293/000089924317005430/doc4.xml","form_type":"4"}},{"id":4454101,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":69013,"kind":"person","name":"Telling Fred","position":1,"cik":"0001382225","reported_name":"Telling Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-13T21:05:29.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock in connection with service to the Company as a director pursuant to the 2012 Equity Incentive Plan that vest equally over each of the four calendar quarters during 2017."}],"balance_after":1355354,"source":{"system":"sec-edgar","filing":"0000899243-17-003780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924317003780/doc4.xml","form_type":"4"}}]}